To me they say that uplisting is almost a done deal, there are 3 new drugs being introduced very soon, we'll have a new director before the year is over and last but not least Jiangbo will anounce an acquisition of a very profitable company within 3 months. On top of that the shareprice will rise to $35 in the first quarter of 2010...
But it all could be my imagination running wild Sorry
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.